Carlo Fremd

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Diffuse Large B Cell Lymphoma

Metastatic Breast Cancer

Top Venues

Pathogens (Basel, Switzerland)

JCO precision oncology

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Anouk E Hiensch, Johanna Depenbusch, Martina E Schmidt, Evelyn M Monninkhof, Mireia Pelaez, Dorothea Clauss, Nadira Gunasekara, Philipp Zimmer, Jon Belloso, Mark Trevaskis, Helene Rundqivst, Joachim Wiskemann, Jana Müller, Maike G Sweegers, Carlo Fremd, Renske Altena, Maciej Gorecki, Rhodé Bijlsma, Lobke van Leeuwen-Snoeks, Daan Ten Bokkel Huinink, Gabe S Sonke, Ainhara Lahuerta, G Bruce Mann, Prudence A Francis, Gary Richardson, Wolfram Malter, Elsken van der Wall, Neil K Aaronson, Elżbieta Senkus, Ander Urruticoechea, Eva M Zopf, Wilhelm Bloch, Martijn M Stuiver, Yvonne Wengström, Karen Steindorf, Katie M O'Brien
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial. Nature medicine (2024)
Ewgenija Gutjahr, Carlo Fremd, Johanna Arnscheidt, Roland Penzel, Jürgen Wacker, Hans-Peter Sinn
Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases. Pathogens (Basel, Switzerland) 12 (12) (2023)
Ewgenija Gutjahr, Carlo Fremd, Johanna Arnscheidt, Roland Penzel, Jürgen Wacker, Hans-Peter Sinn
Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases. Pathogens (Basel, Switzerland) 12 (12) (2023)
Ewgenija Gutjahr, Carlo Fremd, Johanna Arnscheidt, Roland Penzel, Jürgen Wacker, Hans-Peter Sinn
Non-Response of Epstein-Barr Virus-Associated Breast Cancer after Primary Chemotherapy: Report of Two Cases. Pathogens (Basel, Switzerland) 12 (12) (2023)
Stefanie Fischer, Thorsten O Götze, Aurelius G Omlin, Richard D Baird, Keith M Dawson, Christof Zitt, Zita Arany, Gaby Tresch, Ulrike Fiedler, Simone Jeger, Samson Fung, Philippe Legenne, Nicolas Leupin, Andreas Schneeweiß, Carlo Fremd
A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab. JCO precision oncology 6 (2022)